𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease

✍ Scribed by A. Schapira; P. Barone; R. Hauser; Y. Mizuno; W. Poewe; O. Rascol; M. Busse; N. Juhel; L. Salin

Book ID
117753713
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
59 KB
Volume
15
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy, safety, and tolerability of ov
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease
✍ Olivier Rascol; Paolo Barone; Robert A. Hauser; Yoshikuni Mizuno; Werner Poewe; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Abstract The aim of this article is to test the feasibility, in early Parkinson's disease (PD), of an overnight switch from immediate‐release (IR) pramipexole to a new once‐daily extended‐release (ER) formulation. Nonfluctuating patients on pramipexole IR three‐times daily, alone or with levodop

Randomized, double-blind, multicenter ev
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
✍ Robert A. Hauser; Anthony H.V. Schapira; Olivier Rascol; Paolo Barone; Yoshikuni πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 220 KB πŸ‘ 1 views

## Abstract The objective of this study was to evaluate the efficacy and safety of pramipexole extended release (ER) administered once daily in early Parkinson's disease (PD). Pramipexole immediate release (IR) administered three times daily (TID) is an efficacious and generally well‐tolerated trea